Skip to main content

Table 2 Sero-prevalence of viral hepatitis markers among the study population (n = 260)

From: Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania

Marker

No (%)

95% CI

HAV-IgM antibodies

8 (3.1)

1.3 – 6.0

HBsAg

45 (17.3)

12.9 – 22.5

HBc IgM antibodies

6 (2.3)

0.9 – 5.0

HCV Ab

47 (18.1)

13.6 – 23.3

HBsAg & HBc IgM

4 (1.6)

0.4 – 3.9

HBsAg & HCV Ab

10 (3.9)

1.9 – 7.0

Any viral marker

90(34.6)

28.9 – 40.7

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us